Reva Medical (ASX:RVA) this week reported its first quarterly and annual revenues since winning CE Mark approval for its bioresorbable coronary scaffolds, swinging from red to black for the full year.
Get the full story on our sister site, Drug Delivery Business News.
The post Reva Medical swings to black on first sales appeared first on MassDevice.
from MassDevice http://ift.tt/2G7Kxsh
Cap comentari:
Publica un comentari a l'entrada